Alembic Pharmaceuticals inches up on getting USFDA’s final approval for Fenofibrate Capsules

21 Oct 2020 Evaluate

Alembic Pharmaceuticals is currently trading at Rs. 982.05, up by 0.05 points or 0.01% from its previous closing of Rs. 982.00 on the BSE.

The scrip opened at Rs. 983.95 and has touched a high and low of Rs. 987.75 and Rs. 973.80 respectively. So far 9659 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1128.00 on 07-Aug-2020 and a 52 week low of Rs. 436.10 on 23-Mar-2020.

Last one week high and low of the scrip stood at Rs. 989.00 and Rs. 933.50 respectively. The current market cap of the company is Rs. 19302.50 crore.

The promoters holding in the company stood at 69.77%, while Institutions and Non-Institutions held 16.46% and 13.76% respectively.

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Fenofibrate Capsules USP, 67 mg, 134 mg and 200 mg.

Fenofibrate Capsules USP, 67 mg, 134 mg and 200 mg have an estimated market size of $17 million for twelve months ending June 2020. Alembic Pharmaceuticals has a cumulative total of 133 ANDA (115final approvals and 18tentaive approval) from USFDA.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

880.60 -19.30 (-2.14%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×